Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717054 · ClinicalTrials.gov registry record · NA
Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT00717054 is a NA study that has completed, run by Drexel University. The registered enrollment target is 115 participants.
The verdict
NCT00717054, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time, and unplanned hospital admission in patients with high risk for post-operative nausea and vomiting (PONV) treated with oral aprepitant with or without transdermal scopolamine preoperatively.
Interventions
- DRUG Scopolamine
- DRUG Aprepitant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717054
The ClinicalTrials.gov registry entry for NCT00717054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scopolamine is the first listed.
NCT00717054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717054 about?
NCT00717054 is a clinical study titled "Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting". The purpose of this study is to compare the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time, and unplanned hospital admission in patients with high risk for post-operative nausea and vomiting (PONV) treated with oral aprepitant with or without transdermal scopolamine p...
What is the current status of trial NCT00717054?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2008-02. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00717054?
The interventions under investigation include: Scopolamine (DRUG), Aprepitant (DRUG).
Who is sponsoring clinical trial NCT00717054?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.